InspireMD (NASDAQ: NSPR) reported Q1 EPS of ($0.53), $0.28 better than the analyst estimate of ($0.81). Revenue for the quarter came in at $1.24 million versus the consensus estimate of $2 million.

For earnings history and earnings-related data on InspireMD (NSPR) click here.